Pfizer Inc on Wednesday said second-quarter earnings more than doubled on higher sales of its prescription drugs, lower expenses and overseas sales that were boosted by the weak dollar.
FOR SUBSCRIBERSCBP leaders cut out of Trump ad buy decision
FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane
FOR SUBSCRIBERSCBP leaders cut out of Trump ad buy decision
FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane
The company earned $2.78 billion, or 41 cents per share. That compared with $1.27 billion, or 18 cents per share, a year earlier, when Pfizer took large charges for restructuring and merger-related costs.
Excluding special items, Pfizer earned 55 cents per share.














